The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1493
April 25, 2016
View Complete Issue         Table of Contents 2019 
Issue 1493
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
In Brief: New Recommendations for Use of Metformin in Renal Impairment
April 25, 2016 (Issue: 1493)
The FDA has required labeling changes that replace serum creatinine (SCr) with estimated glomerular filtration rate (eGFR) as the parameter used to determine the appropriateness of treatment with the biguanide metformin (Glucophage, and others) in...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 1493
 


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.